دورية أكاديمية
أعرض في EDS

3D engineered tissue models for studying human-specific infectious viral diseases.

التفاصيل البيبلوغرافية
العنوان: 3D engineered tissue models for studying human-specific infectious viral diseases.
المؤلفون: Hwang KS; Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; School of Mechanical Engineering, Yonsei University, Seoul, 03722, Republic of Korea., Seo EU; Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Seoul, 02792, Republic of Korea., Choi N; Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea., Kim J; School of Mechanical Engineering, Yonsei University, Seoul, 03722, Republic of Korea., Kim HN; Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.; School of Mechanical Engineering, Yonsei University, Seoul, 03722, Republic of Korea.; Yonsei-KIST Convergence Research Institute, Yonsei University, Seoul, 03722, Republic of Korea.; Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Seoul, 02792, Republic of Korea.
المصدر: Bioactive materials [Bioact Mater] 2022 Sep 22; Vol. 21, pp. 576-594. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2023).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Ke Ai Publishing Country of Publication: China NLM ID: 101685294 Publication Model: eCollection Cited Medium: Internet ISSN: 2452-199X (Electronic) Linking ISSN: 2452199X NLM ISO Abbreviation: Bioact Mater Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Beijing : Ke Ai Publishing
مستخلص: Viral infections cause damage to various organ systems by inducing organ-specific symptoms or systemic multi-organ damage. Depending on the infection route and virus type, infectious diseases are classified as respiratory, nervous, immune, digestive, or skin infections. Since these infectious diseases can widely spread in the community and their catastrophic effects are severe, identification of their causative agent and mechanisms underlying their pathogenesis is an urgent necessity. Although infection-associated mechanisms have been studied in two-dimensional (2D) cell culture models and animal models, they have shown limitations in organ-specific or human-associated pathogenesis, and the development of a human-organ-mimetic system is required. Recently, three-dimensional (3D) engineered tissue models, which can present human organ-like physiology in terms of the 3D structure, utilization of human-originated cells, recapitulation of physiological stimuli, and tight cell-cell interactions, were developed. Furthermore, recent studies have shown that these models can recapitulate infection-associated pathologies. In this review, we summarized the recent advances in 3D engineered tissue models that mimic organ-specific viral infections. First, we briefly described the limitations of the current 2D and animal models in recapitulating human-specific viral infection pathology. Next, we provided an overview of recently reported viral infection models, focusing particularly on organ-specific infection pathologies. Finally, a future perspective that must be pursued to reconstitute more human-specific infectious diseases is presented.
Competing Interests: The authors declare they have no competing interests.
(© 2022 The Authors.)
References: Acta Biomater. 2021 Sep 15;132:379-400. (PMID: 34157452)
Cell Stem Cell. 2020 Dec 3;27(6):905-919.e10. (PMID: 33142113)
EMBO J. 2020 Oct 15;39(20):e106230. (PMID: 32876341)
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14954-9. (PMID: 19706451)
Virology. 2012 Mar 30;425(1):31-9. (PMID: 22280897)
Arch Med Sci. 2018 Jun;14(4):910-919. (PMID: 30002710)
Science. 2016 May 13;352(6287):816-8. (PMID: 27064148)
Cell Stem Cell. 2016 Dec 1;19(6):703-708. (PMID: 27912091)
Microsyst Nanoeng. 2021 Mar 3;7:19. (PMID: 34567733)
Cell. 2020 Aug 6;182(3):786-786.e1. (PMID: 32763187)
Pathogens. 2021 Jul 20;10(7):. (PMID: 34358063)
Stem Cell Res Ther. 2018 May 11;9(1):134. (PMID: 29751846)
Hepatology. 2020 Jan;71(1):14-30. (PMID: 31206195)
Curr Infect Dis Rep. 2017 Feb;19(2):6. (PMID: 28233188)
J Lab Autom. 2015 Jun;20(3):201-15. (PMID: 25385716)
Nat Biomed Eng. 2021 Aug;5(8):815-829. (PMID: 33941899)
PLoS Pathog. 2020 Oct 22;16(10):e1008899. (PMID: 33091073)
Tissue Eng Part A. 2018 Oct;24(19-20):1468-1480. (PMID: 29732955)
Indoor Air. 2021 Jan;31(1):3-6. (PMID: 33474779)
Genome Med. 2018 Sep 28;10(1):73. (PMID: 30266097)
Sci Transl Med. 2021 Apr 21;13(590):. (PMID: 33723017)
Trends Biotechnol. 2021 Aug;39(8):788-810. (PMID: 33541718)
Mol Aspects Med. 2021 Oct;81:100994. (PMID: 34274157)
Lancet Neurol. 2020 Oct;19(10):826-839. (PMID: 32949543)
Nat Rev Genet. 2001 Dec;2(12):967-77. (PMID: 11733749)
Nat Commun. 2019 May 13;10(1):2144. (PMID: 31086185)
Arch Virol. 2014 Feb;159(2):257-66. (PMID: 23974469)
Neurobiol Dis. 2020 Dec;146:105131. (PMID: 33053430)
SLAS Discov. 2017 Jun;22(5):456-472. (PMID: 28520521)
PLoS Pathog. 2017 Oct 27;13(10):e1006705. (PMID: 29077760)
Trends Microbiol. 2020 Oct;28(10):808-820. (PMID: 32386801)
PLoS Pathog. 2020 Mar 30;16(3):e1008445. (PMID: 32226043)
Cell. 2006 Aug 25;126(4):663-76. (PMID: 16904174)
PLoS One. 2020 Aug 3;15(8):e0237044. (PMID: 32745122)
Signal Transduct Target Ther. 2020 Oct 6;5(1):221. (PMID: 33024073)
Nat Rev Neurol. 2018 Apr 26;14(5):298-313. (PMID: 29697099)
Dermatol Ther. 2020 Sep;33(5):e13549. (PMID: 32390279)
Front Microbiol. 2019 Jan 07;9:3252. (PMID: 30666246)
J Mol Cell Biol. 2021 Jul 6;13(3):185-196. (PMID: 33493263)
Indian J Med Res. 1993 Jan;97:9-13. (PMID: 8387460)
Reprod Health. 2017 Feb 28;14(1):28. (PMID: 28241773)
PLoS One. 2022 Feb 3;17(2):e0263083. (PMID: 35113915)
Biomed Eng Online. 2020 Feb 12;19(1):9. (PMID: 32050989)
Annu Rev Pathol. 2015;10:195-262. (PMID: 25621660)
Drug Discov Today. 2011 Feb;16(3-4):132-9. (PMID: 21146629)
Epidemiol Infect. 1998 Aug;121(1):121-8. (PMID: 9747763)
J Vis Exp. 2012 Feb 22;(60):. (PMID: 22395296)
Altern Lab Anim. 2004 Jun;32 Suppl 1A:43-9. (PMID: 23577433)
Biores Open Access. 2013 Aug;2(4):250-7. (PMID: 23914331)
Stem Cell Res. 2020 Jul;46:101870. (PMID: 32534166)
Trends Microbiol. 2020 Nov;28(11):934-946. (PMID: 32674988)
Cell Stem Cell. 2020 Dec 3;27(6):890-904.e8. (PMID: 33128895)
Cell. 2020 Aug 6;182(3):744-753.e4. (PMID: 32553273)
Front Immunol. 2021 Jun 29;12:689697. (PMID: 34267756)
Viruses. 2021 Jan 19;13(1):. (PMID: 33478119)
Front Microbiol. 2019 May 03;10:873. (PMID: 31130923)
Dermatol Clin. 2002 Apr;20(2):209-15, v. (PMID: 12120435)
J Vis Exp. 2015 Apr 28;(98):e52526. (PMID: 25992921)
Arch Med Sci. 2021 Feb 26;17(2):546-550. (PMID: 33747291)
Sci Rep. 2015 Jul 06;5:11891. (PMID: 26144552)
PLoS Biol. 2018 Jul 27;16(7):e2005315. (PMID: 30052626)
mBio. 2019 Mar 5;10(2):. (PMID: 30837335)
Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):E2165-72. (PMID: 22753481)
Nat Commun. 2020 Sep 11;11(1):4541. (PMID: 32917884)
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17862-7. (PMID: 17095599)
J Vis Exp. 2017 Sep 19;(127):. (PMID: 28994790)
Sci Rep. 2020 Sep 16;10(1):15209. (PMID: 32938988)
J Immunol. 2004 Jan 1;172(1):392-7. (PMID: 14688347)
Front Pharmacol. 2021 Oct 25;12:718484. (PMID: 34759819)
J Tissue Eng. 2020 Oct 14;11:2041731420963981. (PMID: 33117519)
Sci Rep. 2016 Jan 11;6:19103. (PMID: 26752500)
Sci Rep. 2020 May 12;10(1):7865. (PMID: 32398725)
J Med Virol. 2008 Aug;80(8):1468-76. (PMID: 18551613)
J Infect Dis. 1994 Nov;170 Suppl 1:S24-31. (PMID: 7930750)
Methods Mol Biol. 2013;1064:239-51. (PMID: 23996262)
ILAR J. 2001;42(2):127-38. (PMID: 11406715)
Oncotarget. 2015 Nov 3;6(34):35324-43. (PMID: 26473290)
J Virol. 2019 Jul 17;93(15):. (PMID: 31092567)
Cell Discov. 2021 Mar 23;7(1):17. (PMID: 33758165)
Semin Cell Dev Biol. 2021 Mar;111:4-14. (PMID: 32561297)
Cells. 2019 Dec 12;8(12):. (PMID: 31842346)
Tissue Eng Part C Methods. 2021 Jul;27(7):411-420. (PMID: 34107746)
J Biol Chem. 2020 Jun 12;295(24):8325-8330. (PMID: 32350114)
Nat Rev Immunol. 2020 May;20(5):271-272. (PMID: 32296135)
Virol J. 2019 Apr 3;16(1):44. (PMID: 30944006)
Nature. 2000 Aug 17;406(6797):762-7. (PMID: 10963605)
Virology. 2006 Dec 5-20;356(1-2):45-9. (PMID: 16950493)
Antiviral Res. 2016 Aug;132:46-9. (PMID: 27210811)
Biomed Environ Sci. 2018 Feb;31(2):136-145. (PMID: 29606192)
Curr Emerg Hosp Med Rep. 2018;6(3):86-93. (PMID: 32226656)
Emerg Infect Dis. 2020 Nov;26(11):2741-2745. (PMID: 33079056)
Integr Biol (Camb). 2015 Apr;7(4):383-91. (PMID: 25739725)
Virology. 2013 Mar 1;437(1):12-9. (PMID: 23290079)
Lancet Psychiatry. 2020 Oct;7(10):875-882. (PMID: 32593341)
Sci Rep. 2017 Oct 3;7(1):12621. (PMID: 28974702)
J Virol. 2005 Nov;79(21):13350-61. (PMID: 16227257)
J Immunol Res. 2020 Jan 3;2020:5084682. (PMID: 32352019)
Sci Rep. 2016 May 16;6:25835. (PMID: 27180604)
Front Bioeng Biotechnol. 2021 Jan 28;8:620962. (PMID: 33585419)
J Infect Dis. 2007 Apr 15;195(8):1126-36. (PMID: 17357048)
Nature. 2021 May;593(7859):418-423. (PMID: 33727703)
mBio. 2013 Jul 16;4(4):. (PMID: 23860770)
ALTEX. 2018 Nov 19;36(2):177-202. (PMID: 30456412)
PLoS Pathog. 2020 Oct 8;16(10):e1008253. (PMID: 33031460)
Nat Commun. 2018 May 8;9(1):1820. (PMID: 29739942)
Cell Stem Cell. 2017 Mar 2;20(3):397-406.e5. (PMID: 28132835)
Virol Sin. 2016 Oct;31(5):363-379. (PMID: 27822716)
J Biomed Mater Res A. 2019 Aug;107(8):1744-1753. (PMID: 30963688)
Annu Rev Pathol. 2008;3:499-522. (PMID: 18039138)
Biotechnol Bioeng. 2009 Jul 1;103(4):655-63. (PMID: 19472329)
Int J Cosmet Sci. 1992 Dec;14(6):245-64. (PMID: 19272110)
J Invest Dermatol. 2018 Dec;138(12):2540-2549. (PMID: 29870688)
Cell Stem Cell. 2016 May 5;18(5):587-90. (PMID: 26952870)
mBio. 2019 May 7;10(3):. (PMID: 31064833)
J Neuroimmune Pharmacol. 2019 Dec;14(4):661-678. (PMID: 31372820)
Clin Exp Dermatol. 2012 Jul;37(5):534-43. (PMID: 22639919)
Front Cell Neurosci. 2019 Mar 15;13:64. (PMID: 30949028)
Cytotherapy. 2021 Jan;23(1):1-9. (PMID: 33189572)
Trends Mol Med. 2012 Aug;18(8):439-42. (PMID: 22682514)
Front Oncol. 2020 Aug 27;10:1543. (PMID: 32974189)
Exp Dermatol. 2021 Nov;30(11):1699-1704. (PMID: 33751678)
Sci Total Environ. 2021 Jan 15;752:141856. (PMID: 32889280)
Cell Stem Cell. 2016 Aug 4;19(2):258-265. (PMID: 27162029)
J Gastroenterol Hepatol. 2012 Dec;27(12):1858-64. (PMID: 22989301)
Nat Rev Microbiol. 2016 Jul;14(7):421-33. (PMID: 27211790)
PLoS Pathog. 2011 Dec;7(12):e1002413. (PMID: 22174679)
J Vis Exp. 2016 May 09;(111):. (PMID: 27214269)
Microorganisms. 2020 Feb 17;8(2):. (PMID: 32079323)
Viruses. 2020 Sep 08;12(9):. (PMID: 32911874)
Lancet. 2001 May 12;357(9267):1513-8. (PMID: 11377626)
Indian J Pediatr. 2001 Dec;68(12):1135-8. (PMID: 11838568)
Dis Model Mech. 2016 Oct 1;9(10):1203-1210. (PMID: 27483350)
Nat Med. 2019 Sep;25(9):1377-1384. (PMID: 31501601)
J Gen Virol. 2018 Dec;99(12):1529-1550. (PMID: 30325302)
Sci Rep. 2017 Aug 18;7(1):8837. (PMID: 28821762)
Cell. 2016 May 19;165(5):1238-1254. (PMID: 27118425)
Commun Biol. 2021 Dec 2;4(1):1351. (PMID: 34857869)
J Virol. 2020 Jul 30;94(16):. (PMID: 32493817)
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5040-5. (PMID: 22411804)
ALTEX. 2015;32(4):261-74. (PMID: 26536288)
Sci Bull (Beijing). 2021 Apr 30;66(8):783-793. (PMID: 33282445)
Nat Rev Mol Cell Biol. 2020 Oct;21(10):571-584. (PMID: 32636524)
PLoS Med. 2010 Mar 30;7(3):e1000245. (PMID: 20361020)
J Microbiol Biotechnol. 2020 Sep 28;30(9):1412-1419. (PMID: 32522961)
Front Immunol. 2020 Jun 16;11:1441. (PMID: 32612615)
Front Microbiol. 2020 Feb 20;11:214. (PMID: 32153526)
Neuron. 2009 Oct 15;64(1):17-20. (PMID: 19840542)
Nature. 2014 Oct 30;514(7524):642-5. (PMID: 25119033)
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6822-6827. (PMID: 29891677)
AIDS. 2001 May 4;15(7):837-45. (PMID: 11399956)
J Gen Virol. 2006 Jul;87(Pt 7):2011-2019. (PMID: 16760404)
Nat Med. 2016 Oct;22(10):1101-1107. (PMID: 27571349)
Cell. 2020 Aug 6;182(3):734-743.e5. (PMID: 32643603)
Nature. 2016 May 11;534(7606):267-71. (PMID: 27279226)
J Gen Virol. 1974 Jun;23(3):271-9. (PMID: 4836907)
Ann Glob Health. 2021 Oct 21;87(1):103. (PMID: 34722167)
Science. 2020 Nov 13;370(6518):765-766. (PMID: 33184193)
J Mol Endocrinol. 2016 Oct;57(3):185-99. (PMID: 27538988)
J Virol. 2014 Oct;88(19):11264-70. (PMID: 25031345)
Micromachines (Basel). 2016 Sep 08;7(9):. (PMID: 30404334)
Signal Transduct Target Ther. 2021 Jul 7;6(1):255. (PMID: 34234112)
Integr Biol (Camb). 2013 Sep;5(9):1149-61. (PMID: 23925524)
Nat Rev Genet. 2018 Nov;19(11):671-687. (PMID: 30228295)
Nat Rev Microbiol. 2021 Aug;19(8):528-545. (PMID: 33753932)
Epidemiol Infect. 2020 Jun 25;148:e123. (PMID: 32580809)
Arch Pathol Lab Med. 2018 Jun;142(6):700-705. (PMID: 29848038)
J Neurochem. 2008 Aug;106(4):1624-36. (PMID: 18540995)
Biomicrofluidics. 2017 Aug 01;11(4):044109. (PMID: 28852429)
Nat Chem Biol. 2016 Feb;12(2):87-93. (PMID: 26641933)
Nat Immunol. 2005 Apr;6(4):353-60. (PMID: 15785761)
Front Immunol. 2020 Jan 22;11:2. (PMID: 32038654)
Biomaterials. 2018 Nov;182:176-190. (PMID: 30130706)
Sci Rep. 2018 Sep 17;8(1):13877. (PMID: 30224659)
Front Cell Dev Biol. 2020 Jul 10;8:618. (PMID: 32754600)
Front Microbiol. 2016 Nov 02;7:1699. (PMID: 27853451)
N Engl J Med. 2016 May 19;374(20):1981-7. (PMID: 27074377)
mSystems. 2018 Feb 6;3(1):. (PMID: 29435496)
J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):445-8. (PMID: 17514014)
Nat Med. 2006 Mar;12(3):289-95. (PMID: 16520776)
Viruses. 2022 Apr 16;14(4):. (PMID: 35458559)
J Immunol. 2010 Jan 1;184(1):287-95. (PMID: 19949099)
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):325-30. (PMID: 21173246)
Mol Pharm. 2014 Jul 7;11(7):2106-14. (PMID: 24761996)
Cell Host Microbe. 2013 Apr 17;13(4):379-93. (PMID: 23601101)
Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. (PMID: 33113348)
Eur J Pharm Biopharm. 2019 May;138:99-110. (PMID: 29655904)
Proc Natl Acad Sci U S A. 2021 Nov 9;118(45):. (PMID: 34728564)
Viruses. 2020 Nov 12;12(11):. (PMID: 33198291)
Exp Dermatol. 2018 May;27(5):501-511. (PMID: 29518287)
Nature. 2021 Jul;595(7868):596-599. (PMID: 34234347)
J Virol. 2008 Feb;82(4):1665-78. (PMID: 18077728)
J Infect Public Health. 2020 Aug;13(8):1142-1147. (PMID: 32360024)
Nature. 2021 Jan;589(7841):270-275. (PMID: 33116299)
Micromachines (Basel). 2021 Jan 18;12(1):. (PMID: 33477508)
Int J Mol Sci. 2020 Jul 07;21(13):. (PMID: 32645937)
Cell. 2020 May 28;181(5):1036-1045.e9. (PMID: 32416070)
Nat Rev Immunol. 2021 Jul;21(7):441-453. (PMID: 33398129)
Immunol Rev. 2011 Jan;239(1):149-66. (PMID: 21198670)
Sci Rep. 2020 Jul 29;10(1):12767. (PMID: 32728070)
Endocr Relat Cancer. 2013 Mar 26;20(2):R49-64. (PMID: 23447570)
J Water Health. 2011 Jun;9(2):225-40. (PMID: 21942189)
Fluids Barriers CNS. 2018 May 15;15(1):15. (PMID: 29759080)
Science. 2018 Aug 24;361(6404):756-757. (PMID: 30139862)
Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:42-51. (PMID: 24034483)
Biomedicines. 2020 Oct 31;8(11):. (PMID: 33142704)
Nat Commun. 2019 Aug 6;10(1):3526. (PMID: 31387995)
J Virol Methods. 2019 Mar;265:99-104. (PMID: 30582939)
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7431-6. (PMID: 20231459)
Nature. 2020 Dec;588(7839):670-675. (PMID: 33238290)
Sci Rep. 2016 Oct 13;6:34740. (PMID: 27734898)
Sci Transl Med. 2012 Nov 7;4(159):159ra147. (PMID: 23136042)
J Affect Disord. 2020 Oct 1;275:48-57. (PMID: 32658823)
RSC Adv. 2020 Dec 8;10(71):43682-43703. (PMID: 35519701)
Science. 2020 Jul 3;369(6499):50-54. (PMID: 32358202)
Nature. 2011 Jun 08;474(7350):208-11. (PMID: 21654804)
Cell Death Dis. 2018 Jun 18;9(7):719. (PMID: 29915260)
Nat Commun. 2018 Feb 14;9(1):682. (PMID: 29445209)
Dev Cell. 2018 Jul 2;46(1):85-101.e8. (PMID: 29974866)
J Virol. 2019 Apr 17;93(9):. (PMID: 30787148)
Lancet. 2018 Jul 14;392(10142):175-186. (PMID: 30025810)
Sci Transl Med. 2019 Aug 7;11(504):. (PMID: 31391322)
Acta Pharm Sin B. 2018 Sep;8(5):756-766. (PMID: 30258764)
Nat Rev Microbiol. 2021 Jul;19(7):425-441. (PMID: 33824495)
Viruses. 2015 Dec 12;7(12):6590-603. (PMID: 26703714)
Nat Biotechnol. 2010 Feb;28(2):167-71. (PMID: 20118917)
Nat Commun. 2021 Mar 12;12(1):1653. (PMID: 33712573)
J Neurosci. 2017 Feb 22;37(8):2161-2175. (PMID: 28123079)
Artif Organs. 2021 Jun;45(6):548-558. (PMID: 33264436)
فهرسة مساهمة: Keywords: 3D engineered tissue model; In vivo-mimicking; Infection route; Infectious viral disease; Pathology
تواريخ الأحداث: Date Created: 20221007 Latest Revision: 20221009
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9519398
DOI: 10.1016/j.bioactmat.2022.09.010
PMID: 36204281
قاعدة البيانات: MEDLINE
الوصف
تدمد:2452-199X
DOI:10.1016/j.bioactmat.2022.09.010